National Psoriasis Awareness Month offers an opportunity to examine how advances in systemic therapy, combined with ...

The author discusses how Principal Care Management (PCM) enhances oncology care, improves patient outcomes, and boosts ...

Deepak L. Bhatt, MD, MPH, MBA, of Mount Sinai Fuster Heart Hospital, spoke at the recent ASPC 2025 Congress on CVD Prevention ...

FDA approved zopapogene imadenovec, the first therapy for recurrent respiratory papillomatosis, providing an option beyond ...

Given the track record of good outcomes and savings, policy leaders must do more to promote growth of for-profit PACE ...

AI-enhanced mammograms have potential to improve breast cancer screenings, facilitating early detection and empowering ...

Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American ...

Today, the FDA issued a complete response letter (CRL) for vatiquinone (PTC Therapeutics), delaying its potential approval as a treatment for Friedreich ataxia amid efficacy concerns.

There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or ...

Jonathan Thompson, MD, MS, emphasized that broader molecular testing in early-stage non–small cell lung cancer (NSCLC) is essential to guide perioperative treatment decisions, while selective ...

Research reveals a significant decline in reported conflicts of interest among the CDC's and FDA's vaccine advisory committees, challenging Robert F. Kennedy Jr's claims.

Despite nurses often being the first health care workers many patients encounter, they frequently lack adequate tools to optimally evaluate their patients’ conditions, as in the case with myasthenia ...